Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China

L. Zhang, Y. Zhang, X. Shi, Y. Zhang, G. Deng, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom)

Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Session: Diagnostic features of tuberculosis I
Session type: Thematic Poster Session
Number: 2783
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Zhang, Y. Zhang, X. Shi, Y. Zhang, G. Deng, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom). Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China. Eur Respir J 2013; 42: Suppl. 57, 2783

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013


Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Rapid diagnosis of pulmonary tuberculosis by an enzyme-linked immunospot assay using induced sputum cells
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014


Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Positivity of quantiferon-TB tests in sarcoidosis patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Diagnostic accuracy of the novel C-Tb skin test for LTBI, results from two phase III trials
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016

Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011